Study of the in vitro activities of rifaximin and comparator agents against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel flora.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples